Clinical remissions in previously untreated patients with follicular lymphoma after intradermal immunization with a recombinant idiotype vaccine

被引：0
|
作者：
Mikesch, K [1 ]
Bertinetti, C [1 ]
Veelken, H [1 ]
机构：
[1] Univ Freiburg, Med Ctr, D-7800 Freiburg, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Immune responses and clinical outcome of patients with advanced non-Hodgkin's lymphoma after immunization with a novel recombinant idiotype vaccine.
    Veelken, H
    Mauerer, K
    Mikesch, K
    Osterroth, F
    Rosenthal, FM
    Thomas, AK
    Bertinetti, C
    BLOOD, 2003, 102 (11) : 898A - 898A
  • [2] Immunization of non-Hodgkin lymphoma patients with a novel recombinant idiotype vaccine: Results from a phase I clinical trial
    Bertinetti, C
    Dierbach, H
    Mauerer, K
    Mikesch, K
    Veelken, H
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 57 - 57
  • [3] Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma
    Rambaldi, A
    Lazzari, M
    Manzoni, C
    Carlotti, E
    Arcaini, L
    Baccarani, M
    Barbui, T
    Bernasconi, C
    Dastoli, G
    Fuga, G
    Gamba, E
    Gargantini, L
    Gattei, V
    Lauria, F
    Lazzarino, M
    Mandelli, F
    Morra, E
    Pulsoni, A
    Ribersani, M
    Rossi-Ferrini, PL
    Rupolo, M
    Tura, S
    Zagonel, V
    Zaja, F
    Zinzani, P
    Reato, G
    Foa, R
    BLOOD, 2002, 99 (03) : 856 - 862
  • [4] Ofatumumab combined with CHOP in previously untreated patients with follicular lymphoma (FL)
    Czuczman, M. S.
    Viardot, A.
    Hess, G.
    Gadeberg, O. V.
    Pedersen, L. M.
    Gupta, I.
    Lin, T. S.
    Strange, C.
    Windfeld, K.
    Russell, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Identifying Patients With Follicular Lymphoma Who Are Likely to Benefit From an Idiotype Vaccine
    Ansell, Stephen M.
    Suman, Vera J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) : 2748 - 2749
  • [6] Monitoring of minimal residual disease after CHOP and Rituximab in previously untreated follicular lymphoma patients.
    Rambaldi, A
    Carlotti, E
    Baccarani, M
    Barbui, T
    Dastoli, G
    Lauria, F
    Lazzarino, M
    Mandelli, F
    Morra, E
    Pulsoni, A
    Rupolo, M
    Tura, S
    Zaja, F
    Zinzani, P
    Reato, G
    Foa, R
    BLOOD, 2001, 98 (11) : 603A - 603A
  • [7] in Situ Vaccination for Patients with Previously Untreated Follicular Lymphoma: Analysis of Immune Responses
    Czerwinski, Debra K.
    Brody, Joshua
    Kohrt, Holbrook E.
    Hoppe, Richard T.
    Advani, Ranjana H.
    Levy, Ronald
    BLOOD, 2012, 120 (21)
  • [8] Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma
    Flinn, Ian W.
    Thompson, Dana S.
    Boccia, Ralph V.
    Miletello, Gerald
    Lipman, Andrew
    Flora, Douglas
    Cuevas, Daniel
    Papish, Steven W.
    Berdeja, Jesus G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (03) : 365 - 373
  • [9] High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma
    Montoto, Silvia
    Moreno, Carol
    Domingo-Domenech, Eva
    Estany, Cristina
    Oriol, Albert
    Altes, Albert
    Besalduch, Joan
    Pedro, Carme
    Gardella, Santiago
    Escoda, Lourdes
    Asensio, Antoni
    Vivancos, Pilar
    Galan, Pilar
    Fernandez de Sevilla, Alberto
    Ribera, Josep M.
    Briones, Javier
    Colomer, Dolors
    Campo, Elias
    Montserrat, Emili
    Lopez-Guillermo, Armando
    HAEMATOLOGICA, 2008, 93 (02) : 207 - 214
  • [10] Examining the Heterogeneity of Follicular Lymphoma By Multi-Parameter Flow Cyotmetry in Previously Untreated Patients
    Czerwinski, Debra K.
    Long, Steven R.
    Khodadoust, Michael
    Frank, Matthew J.
    Kardosh, Adel
    Okada, Ami
    Robinson, Sophie
    Levy, Ronald
    BLOOD, 2016, 128 (22)
12345